We are live on
!
Find out more
MC
Maverick Capital Portfolio holdings
AUM
$8.67B
1-Year Est. Return
48.76%
This Fund
S&P 500
This Quarter
Est. Return
-2.93%
1 Year Est. Return
+48.76%
3 Year Est. Return
+198.74%
5 Year Est. Return
+110.99%
10 Year Est. Return
+397.6%
AUM
$10.6B
AUM Growth
-$205M
(-1.9%)
Cap. Flow
+$74.8M
Cap. Flow
% of AUM
0.7%
Top 10 Holdings %
Top 10 Hldgs %
60.06%
Holding
915
New
227
Increased
218
Reduced
210
Closed
254
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$234M |
| 2 |
Jones Lang LaSalle
JLL
|
+$172M |
| 3 |
CANO
Cano Health, Inc.
CANO
|
+$113M |
| 4 |
Carvana
CVNA
|
+$84.7M |
| 5 |
IS
ironSource Ltd.
IS
|
+$64.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$89.8M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$73.8M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$73.3M |
| 4 |
Lam Research
LRCX
|
+$73M |
| 5 |
Amazon
AMZN
|
+$71.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 52.75% |
| 2 | Healthcare | 14.85% |
| 3 | Technology | 11.17% |
| 4 | Communication Services | 7.75% |
| 5 | Financials | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Globalstar
GSAT
$10.1B
| $87K | ﹤0.01% |
+3,260
| New | +$64K |
|
577
SLB Ltd
SLB
$72.7B
| $85K | ﹤0.01% |
2,654
-27,843
| -91% | -$855K |
|
578
Levi Strauss
LEVI
$9.49B
| $83K | ﹤0.01% |
+3,012
| New | +$82.8K |
|
|
FOLD
579
DELISTED
Amicus Therapeutics
FOLD
| $82K | ﹤0.01% |
8,522
-4,254
| -33% | -$41.5K |
|
580
Tronox
TROX
$967M
| $82K | ﹤0.01% |
3,642
+2,293
| +170% | +$50.3K |
|
|
PR
581
Permian Resources
PR
$17.4B
| $80K | ﹤0.01% |
+11,868
| New | +$61.3K |
|
582
Acadia Healthcare
ACHC
$2.55B
| $76K | ﹤0.01% |
1,212
-5,061
| -81% | -$317K |
|
583
Advanced Drainage Systems
WMS
$10.6B
| $75K | ﹤0.01% |
642
-7,908
| -92% | -$878K |
|
|
CHX
584
DELISTED
ChampionX
CHX
| $74K | ﹤0.01% |
+2,882
| New | +$70.1K |
|
|
RETA
585
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $74K | ﹤0.01% |
526
+288
| +121% | +$32.5K |
|
586
Encompass Health
EHC
$11.3B
| $73K | ﹤0.01% |
+1,173
| New | +$78.2K |
|
587
Insperity
NSP
$2.03B
| $73K | ﹤0.01% |
+803
| New | +$71.7K |
|
588
Beyond Meat
BYND
$274M
| $68K | ﹤0.01% |
430
-693
| -62% | -$92.1K |
|
589
Pacira BioSciences
PCRX
$1.04B
| $67K | ﹤0.01% |
+1,108
| New | +$70.1K |
|
590
Zions Bancorporation
ZION
$10.1B
| $67K | ﹤0.01% |
+1,274
| New | +$71.3K |
|
|
SUM
591
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $66K | ﹤0.01% |
1,913
-1,340,242
| -100% | -$42.2M |
|
592
Melco Resorts & Entertainment
MLCO
$2.21B
| $65K | ﹤0.01% |
3,947
-1,904
| -33% | -$34.5K |
|
593
Vulcan Materials
VMC
$36.8B
| $64K | ﹤0.01% |
+368
| New | +$65.8K |
|
594
AutoZone
AZO
$51.3B
| $63K | ﹤0.01% |
42
-27
| -39% | -$39.1K |
|
595
ADT
ADT
$5.43B
| $62K | ﹤0.01% |
5,736
-97,890
| -94% | -$983K |
|
596
Tetra Tech
TTEK
$8.77B
| $62K | ﹤0.01% |
+2,530
| New | +$63.7K |
|
597
Baxter International
BAX
$12.8B
| $59K | ﹤0.01% |
+731
| New | +$61.3K |
|
598
Globant
GLOB
$1.65B
| $59K | ﹤0.01% |
270
-804
| -75% | -$177K |
|
599
Calix
CALX
$2.24B
| $58K | ﹤0.01% |
+1,227
| New | +$53.9K |
|
600
Dominion Energy
D
$62.1B
| $58K | ﹤0.01% |
794
-14,068
| -95% | -$1.09M |
|
Similar funds
PCIA
ACM
OAM
NB
IC
SWP
MOACM
MERSOM
Maverick Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Maverick Capital held 915 positions worth $10.6B, down 1.9% from $10.9B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Maverick Capital's Q2 2021 filing shows 227 new, 218 increased, 210 reduced and 254 closed positions. Its largest new stake was Centene: 3,416,815 shares worth $249M. The largest sale was Applied Materials, an estimated $89.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 53% of assets, down from 55% a quarter earlier, followed by Healthcare and Technology.
- Maverick Capital's largest Q2 2021 buy was Centene: 3,416,815 shares worth $249M.
- Maverick Capital added most to Carvana in Q2 2021, an estimated $84.7M increase.
- Maverick Capital's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $89.8M.
- Maverick Capital fully exited Fidelity National Information Services in Q2 2021, selling an estimated $63.1M.
- Maverick Capital's ten largest holdings make up 60% of its $10.6B portfolio in Q2 2021.
- Maverick Capital opened 227 new positions and closed 254 in Q2 2021.
- Maverick Capital's portfolio value fell 1.9% quarter-over-quarter to $10.6B.
Based on Maverick Capital's 13F filing for Q2 2021, filed 16 Aug 2021.